Aurora Cannabis (TSE:ACB) Reaches New 12-Month High at $6.74

Shares of Aurora Cannabis Inc. (TSE:ACB) reached a new 52-week high on Thursday . The company traded as high as C$6.74 and last traded at C$6.49, with a volume of 1819661 shares changing hands. The stock had previously closed at C$6.44.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on ACB shares. Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating and set a C$0.80 price objective for the company in a research report on Friday, February 9th. CIBC reduced their price target on shares of Aurora Cannabis to C$6.00 and set a “neutral” rating for the company in a research report on Wednesday, February 21st. Finally, Jefferies Financial Group decreased their price target on shares of Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating on the stock in a report on Tuesday, February 27th.

Aurora Cannabis Trading Down 7.9 %

The stock’s 50 day simple moving average is C$2.75 and its 200 day simple moving average is C$1.43. The firm has a market cap of C$323.42 million, a PE ratio of -0.08 and a beta of 2.83. The company has a debt-to-equity ratio of 18.51, a quick ratio of 2.48 and a current ratio of 3.79.

Aurora Cannabis (TSE:ACB) last announced its earnings results on Thursday, February 8th. The company reported C($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.10) by C($0.10). The company had revenue of C$72.61 million during the quarter, compared to analysts’ expectations of C$63.50 million. Aurora Cannabis had a negative return on equity of 137.28% and a net margin of 151.71%. On average, sell-side analysts forecast that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.